These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3936236)

  • 1. Serum concentrations of valproic acid: influence of dose and comedication.
    May T; Rambeck B
    Ther Drug Monit; 1985; 7(4):387-90. PubMed ID: 3936236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum concentrations of lamotrigine in epileptic patients: the influence of dose and comedication.
    May TW; Rambeck B; Jürgens U
    Ther Drug Monit; 1996 Oct; 18(5):523-31. PubMed ID: 8885114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the factors influencing anti-epileptic drug concentrations--valproic acid.
    Ieiri I; Higuchi S; Hirata K; Yamada H; Aoyama T
    J Clin Pharm Ther; 1990 Oct; 15(5):351-63. PubMed ID: 2289937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluctuations of unbound and total phenytoin concentrations during the day in epileptic patients on valproic acid comedication.
    May T; Rambeck B
    Ther Drug Monit; 1990 Mar; 12(2):124-8. PubMed ID: 2107607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does lamotrigine influence valproate concentrations?
    Mataringa MI; May TW; Rambeck B
    Ther Drug Monit; 2002 Oct; 24(5):631-6. PubMed ID: 12352935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbamazepine metabolism in humans: effect of concurrent anticonvulsant therapy.
    Ramsay RE; McManus DQ; Guterman A; Briggle TV; Vazquez D; Perchalski R; Yost RA; Wong P
    Ther Drug Monit; 1990 May; 12(3):235-41. PubMed ID: 2112276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of coadministered antiepileptic drugs on serum phenobarbital concentrations in epileptic patients: quantitative analysis based on a suitable transforming factor.
    Fukuoka N; Tsukamoto T; Uno J; Kimura M; Morita S
    Biol Pharm Bull; 2004 Dec; 27(12):2000-5. PubMed ID: 15577220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of oxcarbazepine and methsuximide on lamotrigine concentrations in epileptic patients with and without valproic acid comedication: results of a retrospective study.
    May TW; Rambeck B; Jürgens U
    Ther Drug Monit; 1999 Apr; 21(2):175-81. PubMed ID: 10217337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of co-medications on lamotrigine clearance in Japanese children with epilepsy.
    Takeuchi T; Natsume J; Kidokoro H; Ishihara N; Yamamoto H; Azuma Y; Ito Y; Kurahashi N; Tsuji T; Suzuki M; Itomi K; Yamada K; Kurahashi H; Abe S; Okumura A; Maruyama K; Negoro T; Watanabe K; Kojima S
    Brain Dev; 2016 Sep; 38(8):723-30. PubMed ID: 27033151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum concentrations of topiramate in patients with epilepsy: influence of dose, age, and comedication.
    May TW; Rambeck B; Jürgens U
    Ther Drug Monit; 2002 Jun; 24(3):366-74. PubMed ID: 12021627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum concentrations of carbamazepine and its epoxide and diol metabolites in epileptic patients: the influence of dose and comedication.
    Rambeck B; May T; Juergens U
    Ther Drug Monit; 1987 Sep; 9(3):298-303. PubMed ID: 3672573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentrations of stiripentol in children and adults with epilepsy: the influence of dose, age, and comedication.
    May TW; Boor R; Mayer T; Jürgens U; Rambeck B; Holert N; Korn-Merker E; Brandt C
    Ther Drug Monit; 2012 Aug; 34(4):390-7. PubMed ID: 22743350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum concentrations of rufinamide in children and adults with epilepsy: the influence of dose, age, and comedication.
    May TW; Boor R; Rambeck B; Jürgens U; Korn-Merker E; Brandt C
    Ther Drug Monit; 2011 Apr; 33(2):214-21. PubMed ID: 21383651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability of phenytoin, carbamazepine and valproate concentrations in a clinic population.
    Leppik IE
    Epilepsy Res Suppl; 1988; 1():85-90. PubMed ID: 3149581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nomogram for the prediction of unbound phenytoin concentrations in patients on a combined treatment of phenytoin and valproic acid.
    May TW; Rambeck B; Nothbaum N
    Eur Neurol; 1991; 31(1):57-60. PubMed ID: 2015840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of discontinuation of phenytoin, carbamazepine, and valproate on concomitant antiepileptic medication.
    Duncan JS; Patsalos PN; Shorvon SD
    Epilepsia; 1991; 32(1):101-15. PubMed ID: 1985818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased valproate serum concentrations upon carbamazepine cessation.
    Jann MW; Fidone GS; Israel MK; Bonadero P
    Epilepsia; 1988; 29(5):578-81. PubMed ID: 3137021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma concentrations of valproate during maintenance therapy in epileptic children.
    Lundberg B; Nergårdh A; Boréus LO
    J Neurol; 1982; 228(2):133-41. PubMed ID: 6185649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of old age and enzyme inducing comedication on the pharmacokinetics of valproic acid at steady-state: A case-matched evaluation based on therapeutic drug monitoring data.
    Fattore C; Messina S; Battino D; Croci D; Mamoli D; Perucca E
    Epilepsy Res; 2006 Aug; 70(2-3):153-60. PubMed ID: 16730950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of antiepileptic drug comedication on lamotrigine concentrations.
    Lovrić M; Čajić I; Petelin Gadže Ž; Klarica Domjanović I; Božina N
    Croat Med J; 2018 Feb; 59(1):13-19. PubMed ID: 29498493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.